Abattis Bioceuticals Corp. (ATTBF)

[GreenBrickRoad]

SmallCapPower | November 15, 2017: Emerald Health Therapeutics Inc. (TSXV:EMH) announced on Monday that its licensed producer application for the Pure Sunfarms Delta 3 greenhouse facility received positive review from Health Canada’s Office of Medical Cannabis. The news sent the stock price of Emerald Health Therapeutics surging 21% on Monday and its share price has risen about 43% during the past four trading sessions as sector takeover speculation in Canada intensifies following the unsolicited offer by Aurora Cannabis (TSX:ACB) for CanniMed Therapeutics Inc. (TSX:CMED), as well as CanniMed’s desire to acquire Newstrike Resources Ltd. (TSXV:HIP).

Geez.. I guess I should have diversified at least a little into EMH after the Northern Vine partnership was announced. Look what a little acquisition speculation can whip up..